These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2759254)

  • 1. Clinical experience with CA-50 in the serum of carcinoma patients.
    Habib NA; Hershman MJ; Kelly SB; Taylor G; Williamson RC; Wood CB
    Eur J Surg Oncol; 1989 Aug; 15(4):361-6. PubMed ID: 2759254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of CA-50 radioimmunoassay inhibition test in the differential diagnosis of benign and malignant breast disease.
    Hershman MJ; Habib NA; Kelly SB; Beynon J; Williamson RC; Davies PW; Wood CB
    Eur J Surg Oncol; 1988 Oct; 14(5):413-5. PubMed ID: 3181445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of tumour marker measurements upon management of patients with carcinoma of the ovary.
    Rustin GJ
    Dis Markers; 1991; 9(3-4):153-8. PubMed ID: 1813207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of the carbohydrate antigen CA-50 in pancreatic disease.
    Blind PJ; Dahlgren ST
    Acta Chir Scand; 1987 Jan; 153(1):45-9. PubMed ID: 3472420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of monoclonal antibody OC 125 in gynecological oncology].
    Wu AR; Wang EY; Wang XX; Jia XH; Li L
    Zhonghua Zhong Liu Za Zhi; 1988 Mar; 10(2):132-6. PubMed ID: 3208653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of CA-125 levels in the sera of patients with non-ovarian carcinomas and non-malignant diseases.
    Marechal F; Berthiot G; Kritly T; Legrand MG; Deltour G; Cattan A
    Anticancer Res; 1989; 9(3):593-8. PubMed ID: 2764505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
    Suzuki H; Teshima K; Noda K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of an immunoradiometric assay for CA15-3 antigen associated with human mammary carcinomas: comparison with carcinoembryonic antigen.
    Fujino N; Haga Y; Sakamoto K; Egami H; Kimura M; Nishimura R; Akagi M
    Jpn J Clin Oncol; 1986 Dec; 16(4):335-46. PubMed ID: 3467106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
    Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
    Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of a monoclonal-antibody-defined antigen (90K) in the sera of patients with ovarian cancer.
    Scambia G; Panici PB; Baiocchi G; Perrone L; Iacobelli S; Mancuso S
    Anticancer Res; 1988; 8(4):761-4. PubMed ID: 3178164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas.
    Klug TL; Bast RC; Niloff JM; Knapp RC; Zurawski VR
    Cancer Res; 1984 Mar; 44(3):1048-53. PubMed ID: 6198078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical use of CA-125 in gynecology. Preliminary experience].
    Mayerson D; Badía J; Wild R; Barrena N; Johnson MC; Foradori A
    Rev Chil Obstet Ginecol; 1989; 54(5):301-6. PubMed ID: 2490419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monoclonal antibodies. Their usefulness in the diagnosis of malignant tumors of the digestive system].
    Campos Campos F; Romero Navarro MA; Gutiérrez Samperio C; Esquivel P; Gaviño Chapa JF
    Rev Gastroenterol Mex; 1989; 54(4):193-8. PubMed ID: 2616981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum CA-15.3 and CEA patterns in postsurgical follow-up, and in monitoring clinical course of metastatic cancer in patients with breast carcinoma.
    al-Jarallah MA; Behbehani AE; el-Nass SA; Temim L; Ebraheem AK; Ali MA; Szymendera JJ
    Eur J Surg Oncol; 1993 Feb; 19(1):74-9. PubMed ID: 8436243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum level of the tumor marker CA 125 in ovarian pathology].
    Bagni B; Pansini FS; Feggi LM; Prandini N; Mollica G
    Radiol Med; 1987 Nov; 74(5):448-50. PubMed ID: 3479814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preliminary application of carbohydrate antigen CA-50 radioimmunoinhibition test in diagnosing and monitoring cancers].
    Chen ZZ; Fan ZF; Su P
    Zhonghua Zhong Liu Za Zhi; 1987 Nov; 9(6):436-8. PubMed ID: 2838242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum carbohydrate 19-9 Tm and bronchial cancer. Comparative study with another tumor marker, carcinoembryonic antigen].
    Bisset JP; Kleisbauer JP; Roux F; Treffot MJ
    Pathol Biol (Paris); 1985 Jun; 33(6):672-6. PubMed ID: 3900886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with CA 15.3 as a tumor marker in breast cancer.
    Barros AC; Fry W; Nazario AC; Santos MO; Sato MK
    Eur J Surg Oncol; 1994 Apr; 20(2):130-3. PubMed ID: 8181577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of the tumour markers CA 125 II, CA 72-4, CASA and CYFRA 21-1 in ovarian carcinoma.
    Hasholzner U; Baumgartner L; Stieber P; Meier W; Hofmann K; Fateh-Moghadam A
    Anticancer Res; 1994; 14(6B):2743-6. PubMed ID: 7532929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CA 19-9 in early cancers of the bronchi. Comparison with the carcinoembryogenic antigen].
    Vindimian M; Lafitte JJ; Wattre P
    Biomed Pharmacother; 1987; 41(4):191-5. PubMed ID: 3476162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.